Abstract LB-70: Tackling a clinical challenge: Using microRNAs to differentiate between low-and high-risk Pancreatic Cysts .
Jennifer Permuth Wey(Moffitt Cancer Center), Mokenge P. Malafa(Moffitt Cancer Center), Mark C. Lloyd(Moffitt Cancer Center), Domenico Coppola(Florida College), Kate Fisher(International Drug Development Institute (Belgium)), Jason Klapman(Susan Thompson Buffett Foundation), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Susan McCarthy(University of South Florida), Agnieszka Kasprzak(Moffitt Cancer Center), Timothy J. Yeatman(University of South Florida), Y. Ann Chen(Zhejiang Chinese Medical University)
Cited by 0
Related Papers
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k